RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.250
+0.100 (8.70%)
Dec 20, 2024, 4:00 PM EST - Market closed
RenovoRx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 9.56 | 1.17 | 4.39 | 15.19 | 1.8 | 2.1 |
Short-Term Investments | - | - | 2.05 | - | - | - |
Cash & Short-Term Investments | 9.56 | 1.17 | 6.44 | 15.19 | 1.8 | 2.1 |
Cash Growth | 196.44% | -81.79% | -57.61% | 746.35% | -14.69% | - |
Prepaid Expenses | 0.47 | 0.19 | 0.83 | 1.09 | 0.12 | 0.14 |
Restricted Cash | - | - | - | - | - | 0.02 |
Other Current Assets | - | 0.1 | - | - | - | - |
Total Current Assets | 10.03 | 1.47 | 7.27 | 16.28 | 1.91 | 2.27 |
Property, Plant & Equipment | - | - | - | 0.01 | - | - |
Other Long-Term Assets | - | - | - | - | 0 | 0 |
Total Assets | 10.03 | 1.47 | 7.27 | 16.29 | 1.91 | 2.27 |
Accounts Payable | 0.69 | 0.56 | 0.53 | 0.53 | 0.16 | 0.54 |
Accrued Expenses | 1.09 | 0.61 | 0.57 | 0.41 | 0.31 | 0.23 |
Short-Term Debt | - | - | - | - | 2.65 | - |
Current Portion of Long-Term Debt | - | - | - | - | 0.12 | - |
Other Current Liabilities | - | - | - | - | 0.86 | 0.04 |
Total Current Liabilities | 1.77 | 1.18 | 1.1 | 0.94 | 4.1 | 0.81 |
Long-Term Debt | - | - | - | - | 0.02 | - |
Other Long-Term Liabilities | 1.19 | 3.29 | - | - | - | - |
Total Liabilities | 2.96 | 4.47 | 1.1 | 0.94 | 4.12 | 0.81 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 54.41 | 38.4 | 37.32 | 36.63 | 0.3 | 0.24 |
Retained Earnings | -47.34 | -41.41 | -31.17 | -21.28 | -14.96 | -11.16 |
Comprehensive Income & Other | - | - | 0.02 | - | - | - |
Total Common Equity | 7.07 | -3 | 6.16 | 15.35 | -14.66 | -10.93 |
Shareholders' Equity | 7.07 | -3 | 6.16 | 15.35 | -2.21 | 1.47 |
Total Liabilities & Equity | 10.03 | 1.47 | 7.27 | 16.29 | 1.91 | 2.27 |
Total Debt | - | - | - | - | 2.79 | - |
Net Cash (Debt) | 9.56 | 1.17 | 6.44 | 15.19 | -1 | 2.1 |
Net Cash Growth | 196.44% | -81.79% | -57.61% | - | - | - |
Net Cash Per Share | 0.51 | 0.11 | 0.71 | 2.91 | -0.45 | 0.97 |
Filing Date Shares Outstanding | 24 | 16.87 | 9.1 | 9.03 | 2.23 | 2.18 |
Total Common Shares Outstanding | 24 | 10.69 | 9.1 | 8.93 | 2.23 | 2.18 |
Working Capital | 8.26 | 0.29 | 6.16 | 15.34 | -2.19 | 1.46 |
Book Value Per Share | 0.29 | -0.28 | 0.68 | 1.72 | -6.56 | -5.02 |
Tangible Book Value | 7.07 | -3 | 6.16 | 15.35 | -14.66 | -10.93 |
Tangible Book Value Per Share | 0.29 | -0.28 | 0.68 | 1.72 | -6.56 | -5.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.